INS and metabolic disease: Together, these results highlight the role of REPS1 as a key signaling protein impaired in insulin resistance and suggest that enhancing REPS1 phosphorylation could be a potential therapeutic strategy to improve insulin sensitivity and restore glucose uptake in metabolic disorders such as T2D.